DiagCor Bioscience Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

DiagCor Bioscience General Information

Description

Developer of flow-through hybridization technology designed to offer a range of products and services related to RNA and DNA analysis. The company's flow-through hybridization technology offers prenatal diagnosis, genetic testing, parentage investigation, cancer testing and infectious disease identification, enabling doctors and research institutes to simplify lab workflow and reduce overheads.

Contact Information

Website
www.diagcor.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 28/F, Tower A Billion Center
  • Kowloon Bay
  • Hong Kong
  • Hong Kong
+852 2147
Primary Industry
Diagnostic Equipment
Other Industries
Medical Supplies
Vertical(s)
TMT, HealthTech, Life Sciences, Oncology
Corporate Office
  • 28/F, Tower A Billion Center
  • Kowloon Bay
  • Hong Kong
  • Hong Kong
+852 2147

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DiagCor Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-May-2016 Completed Generating Revenue
To view DiagCor Bioscience’s complete valuation and funding history, request access »

DiagCor Bioscience Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

DiagCor Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201504714-D0 Rapid and sensitive detection of mycobacteria using isothermal nucleic acid amplification Inactive 20-Mar-2015
WO-2014139330-A1 Rapid genotyping analysis and kits thereof Inactive 15-Mar-2013
WO-2012066499-A1 Flow-through apparatus Inactive 17-Nov-2010
WO-2012066500-A1 Flow-through apparatus Inactive 17-Nov-2010
WO-2011139750-A1 Rapid genotyping analysis for human papillomavirus and the device thereof Inactive 29-Apr-2010 C12Q1/708
To view DiagCor Bioscience’s complete patent history, request access »

DiagCor Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DiagCor Bioscience Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Kenson Ventures Venture Capital Minority
To view DiagCor Bioscience’s complete investors history, request access »

Ready to get started?

Request a free trial

DiagCor Bioscience FAQs

  • When was DiagCor Bioscience founded?

    DiagCor Bioscience was founded in 2006.

  • Where is DiagCor Bioscience headquartered?

    DiagCor Bioscience is headquartered in Hong Kong, Hong Kong.

  • What is the size of DiagCor Bioscience?

    DiagCor Bioscience has 50 total employees.

  • What industry is DiagCor Bioscience in?

    DiagCor Bioscience’s primary industry is Diagnostic Equipment.

  • Is DiagCor Bioscience a private or public company?

    DiagCor Bioscience is a Private company.

  • What is DiagCor Bioscience’s current revenue?

    The current revenue for DiagCor Bioscience is .

  • Who are DiagCor Bioscience’s investors?

    Kenson Ventures has invested in DiagCor Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process